Skip to main content

Incident/ Deviation/ Investigation


Why deviation management is performed 
— to find and fix problems.

Effectively managing deviations in pharmaceutical industry is crucial to ensuring product quality, regulatory compliance and patient safety.

Deviation is departure from approved procedure due to unexpected situations, like- breakdown of the equipment/ facility or any other reasons 

Examples of deviations are-
Equipment failure 
Procedure departure 
Human failure 
Material, process and system related failure 

Deviation can be categorised on basis of severity of impact -
1. Low severity _ Minor deviation- Having no direct or indirect impact on product quality and patient safety 
2. Medium severity _ Major deviation - May have indirect impact on product quality and patient safety 
3. High severity _ Critical deviation - May have direct impact to the product quality and patient safety 

DMAIC approach being followed to handling of deviation

Investigate the deviation following DMAIC approach, identify the root cause following different techniques (Fish bone diagram and Why Why analysis) and initiate corrective and preventive measures.

Basic tools such as 5-Whys,
PEMME (personnel, equipment,
method, materials, environment), and
fishbone diagrams.

Description of deviation contains identification initial assessment -
1. What happened
2. Where happened
3. When happened
4. Who observed
5. Assessment of deviation and its impact

Cancelling and Reopening of Deviations: Cancellation of open deviation records usually is allowed if there are duplicates, but such instances should be documented. It is important to explain why multiple records were generated for the same event or if a raised deviation does not qualify as such. Additionally, it is generally permissible to reopen a closed deviation for minor corrections, clarifications, or additions, but modifications or additions must adhere to the original intent of the investigation or root-cause analysis. Unless they are self-evident, rationale behind changes should be documented.

The following Methodology techniques may be employed as necessary to facilitate the determination of the root cause-
A. 5 Why analysis
B. Cause and Effect analysis - Ishikawa or ‘fishbone’ diagram
C. Brainstorming
D. FMEA or process flow chart
E. Fault Tree Analysis
F. Any other suitable tool(s)

All minor/major/critical deviations shall be investigated thoroughly with chronology of events to identify the root cause, defining corrective and preventive actions & assess the impact to product quality.

cross functional team shall be formed for investigation, which is headed by the QA.

Root cause shall be identified by different tools like 5 Why analysis, cause and effect diagram, brainstorming etc.

5 why shall be used for investigation of human error and probable root cause/ contributing factors shall be identified by the cause and effect diagram and brainstorming.

once probable root cause/ contributing factor is identified, further investigation shall be performed through other technique to identify the root cause.

DMAIC (Define, measure, analyse, Improve and control) approach shall be used to perform the investigation.

Define- Description of deviation
Measure- Review of historical data
Analyse- Summary of investigation and identified root cause
Improve and control- Propose corrective and preventive action

Define_ 

Comments

Popular posts from this blog

Change Management System

US Market (Supplement): Post approval drug manufacturing supplement for NDAs/ ANDA submitted to FDA for Major or Moderate manufacturing change. Major change - If a manufacturing change is considered to be major, an applicant must submit and receive FDA approval of a prior-approval supplement (PAS) before the drug product made with the change is distributed. Moderate change- If a manufacturing change is considered to be moderate, an applicant must submit a supplement at least 30 days before the drug product is distributed (a CBE-30 supplement) or, in some cases, submit a supplement at the time of distribution (a CBE-0 supplement).  “CBE” means “changes-being-effected”. Post manufacturing supplement - 1. CBE 0 (Change being effected before 00 days): 2. CBE 30 (Change being effected before 30 days): 3. PAS (Prior approval supplement): EUROPE Market (Variation): A variation to the terms of a marketing authorization is an amendment to the contents of the docume...

NVPC

NVPC Online NVPC: Make= Beckman; Model= Met one 6015P; Capacity= 1CFM SOFTWARE= EnVigil Critical alarm: Critical alarms are those alarms when generated indicate excursion which may impact the product quality. Alarm generated in location where the NVPC probe is in close proximity to the product/ sterile container closure/ product contact path. Location for critical alarms includes grade A location - Filling station, Bunging station, Bunging Hopper station, Portable cart, IOS station, AGV station, Near lyophilizer door open, between lyophilizers (near Lyo) and Lyo LAF (rigid barrier transfer conveyor). Critical alarms include the following- 1.     Particle count excursion beyond the acceptance criteria at a particular location. 2.     Sensor Failure, Counter Flow Failure, ERROR or SKIPPED message. Ensure and verify the status of counter flow to meet the below set limit- Target Counter flow – 1.0 CFM. Minimum counter flow: ...

Air velocity measurement and correlation to smoke study

Air velocity measurement As part of risk assessment this evaluation should also consider the selection of locations for the critical control points for monitoring air velocity as well as viable and non-viable particles. 1. Problem Statement- Where should airflow velocity measurements be taken with respect to a filling line or other aseptic processing areas? Recommendation Airflow velocity measurements should be taken at locations where meaningful and reproducible results can be obtained. This is typically at a distance of 6 inches from the filter face . Rationale for Recommendation The primary reason for airflow velocity measurements in unidirectional airflow areas (e.g., areas where product, product contact packaging components, and product contact surfaces are exposed) is to assure there is adequate airflow to protect the materials from external airborne contamination . Accurate measurements can be taken and changes over time detected when airflow velocities are e...